Discover Tenders by Non Decaffeinated Coffee Sector

Find the most relevant tenders for Non Decaffeinated Coffee. Access the latest tender notices from various government and private organizations published across hundreds of websites and newspapers.Obtain complete and accurate information on Non Decaffeinated Coffee tenders, including all tender documents, RFPs, RFQs,and more. Utilize our advanced filters to search for Non Decaffeinated Coffee tenders by organization, tender value, opening and closing dates, and more.

Filter Your Search

Country

Sector

Region

Funding Agency

Conclusion Of Non Exclusive Discount Agreements Pursuant To Section 130A Paragraph 8 Sgb V For The Active Ingredients Mentioned With The Possibility Of Conclusion Within The Framework Of The So Called Open House Procedure

Deadline: 31 Dec 2026

Germany

Ref. No.: 6229837

EMD:Ref Document

Bid Value: Ref Document

473 Days Left

Conclusion Of Non Exclusive Discount Agreements Pursuant To Section 130A Paragraph 8 130C Paragraph 1 Sgb V For Medicinal Products Containing The Active Ingredient Alirocumab C10Ax14 Within The Framework Of A So Called Open House Model

Deadline: 31 May 2026

Germany

Ref. No.: 6227129

EMD:Ref Document

Bid Value: Ref Document

259 Days Left

Conclusion Of Non Exclusive Discount Agreements Pursuant To Section 130A Paragraph 8 130C Paragraph 1 Sgb V For Medicinal Products Containing The Active Ingredient Bempedoic Acid C10Ax15 Within The Framework Of A So Called Open House Model

Deadline: 31 May 2026

Germany

Ref. No.: 6227068

EMD:Ref Document

Bid Value: Ref Document

259 Days Left

Conclusion Of Non Exclusive Discount Agreements Pursuant To Section 130A Paragraph 8 130C Paragraph 1 Sgb V For Medicinal Products Containing The Active Ingredient Lisdexamfetamine N06Ba12 Within The Framework Of A So Called Open House Model

Deadline: 31 May 2026

Germany

Ref. No.: 6225281

EMD:Ref Document

Bid Value: Ref Document

259 Days Left

Conclusion Of Non Exclusive Discount Agreements Pursuant To Section 130A Paragraph 8 130C Paragraph 1 Sgb V For Medicinal Products Containing The Active Ingredient Etanercept L04Ab01 Within The Framework Of A So Called Open House Model

Deadline: 31 May 2026

Germany

Ref. No.: 6224846

EMD:Ref Document

Bid Value: Ref Document

259 Days Left

Conclusion Of Non Exclusive Discount Agreements Pursuant To Section 130A Paragraph 8 130C Paragraph 1 Sgb V For Medicinal Products Containing The Active Ingredient Ustekinumab L04Ac05 Within The Framework Of A So Called Open House Model

Deadline: 31 May 2026

Germany

Ref. No.: 6224416

EMD:Ref Document

Bid Value: Ref Document

259 Days Left

Conclusion Of A Non Exclusive Framework Agreement For Planning Services For Landscape Conservation Planning In Accordance With Hoai Environmental Expert Contributions And Special Services In The Open House Procedure

Deadline: 31 Mar 2026

Germany

Ref. No.: 6224223

EMD:Ref Document

Bid Value: Ref Document

198 Days Left

Conclusion Of Non Exclusive Discount Agreements Pursuant To Section 130A Paragraph 8 130C Paragraph 1 Sgb V For Medicinal Products Containing The Active Ingredients Bempedoic Acid And Ezetimibe C10Ba10 Within The Framework Of A So Called Open House

Deadline: 31 May 2026

Germany

Ref. No.: 6223493

EMD:Ref Document

Bid Value: Ref Document

259 Days Left

Conclusion Of Non Exclusive Discount Agreements According To Section 130A Paragraph 8 Sgb V Open House Model

Deadline: 01 Jun 2026

Germany

Ref. No.: 6223117

EMD:Ref Document

Bid Value: Ref Document

260 Days Left

Conclusion Of Non Exclusive Discount Agreements Pursuant To Section 130A Paragraph 8 130C Paragraph 1 Sgb V For Medicinal Products Containing The Active Ingredient Naloxegol A06Ah03 Within The Framework Of A So Called Open House Model

Deadline: 31 May 2026

Germany

Ref. No.: 6222391

EMD:Ref Document

Bid Value: Ref Document

259 Days Left

Conclusion Of A Non Exclusive Discount Agreement According To Section 130A Paragraph 8 Sgb V For Medicinal Products Containing The Active Ingredient Lisdexamfetamine Atc Code N06Ba12

Deadline: 27 May 2026

Germany

Ref. No.: 6189945

EMD:Ref Document

Bid Value: Ref Document

255 Days Left

Conclusion Of A Non Exclusive Discount Agreement According To Section 130A Paragraph 8 Sgb V For Medicinal Products Containing The Active Ingredient Fusidic Acid Atc Code D06Ax01

Deadline: 27 May 2026

Germany

Ref. No.: 6189911

EMD:Ref Document

Bid Value: Ref Document

255 Days Left

Conclusion Of A Non Exclusive Discount Agreement According To Section 130A Paragraph 8 Sgb V For Medicinal Products Containing The Active Ingredient Combination Of Olodaterol And Tiotropium Bromide Atc Code R03Al06

Deadline: 27 May 2026

Germany

Ref. No.: 6184473

EMD:Ref Document

Bid Value: Ref Document

255 Days Left

Conclusion Of A Non Exclusive Discount Agreement According To Section 130A Paragraph 8 Sgb V For Medicinal Products Containing The Active Ingredient Trientine Atc Code A16Ax12

Deadline: 27 May 2026

Germany

Ref. No.: 6183142

EMD:Ref Document

Bid Value: Ref Document

255 Days Left

Conclusion Of A Non Exclusive Drug Discount Agreement Pursuant To Section 130A Paragraph 8 Sgb V By Means Of An Open House Model For Drugs With The Trade Name Oralair Atc Code According To Who V01Aa02

Deadline: 31 Jul 2026

Germany

Ref. No.: 6175344

EMD:Ref Document

Bid Value: Ref Document

320 Days Left

Showing 26311 to 26325 of 26667 results

‹
1
2
...
1752
1753
1754
1755
1756
1757
1758
...
1777
1778
›

Discover Tenders by Non Decaffeinated Coffee Sector

Filter Your Search

Tenders by Countries

Browse Popular Sectors

Projects by Regions

Funding Agency

Support

CONTACT DETAILS

Discover Tenders by Non Decaffeinated Coffee Sector

Filter Your Search

FREE Trial plan for all new users!